Aspire Biopharma Holdings, Inc.
Developing a nano-platform for rapid, sublingual delivery of reformulated medications.
ASBP | NDAQ
Overview
Corporate Details
- ISIN(s):
- KYG7207P1110 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 23150 FASHION DRIVE, SUITE 232, 33928 ESTERO
- Website:
- https://www.powerupacq.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company developing a disruptive technology for novel drug delivery. The company's core focus is a patent-pending sublingual absorption platform that uses nanotechnology to deliver medications rapidly under the tongue. This method allows drugs to bypass the gastrointestinal tract and liver, potentially improving efficacy, speeding up response times, and perfecting dosage management. Aspire's strategy involves reformulating existing, FDA-approved drugs and supplements for various applications, including analgesics, erectile dysfunction, and traumatic brain injury treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aspire Biopharma Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aspire Biopharma Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aspire Biopharma Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
